NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Vaccines platforms and COVID-19: what you need to know

Controlled Human Infection Models To Accelerate Vaccine

PDF) Vaccine Strategies to Elicit Mucosal Immunity

Frontiers Reduced immunogenicity of a live Salmonella enterica

World experts to gather for IVI symposium on hepatitis E – IVI

Mucosal vaccines — fortifying the frontiers

Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect

PDF) Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated

Controlled Human Infection Models To Accelerate Vaccine

Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and

News - VaccineNation